FDA

FDA Rolls Out New Food Safety Regulation

Last Friday, the U.S. Food and Drug Administration released a new set of rules for both produced and imported foods to help combat foodborne-related illnesses.

FDA to toughen NSAID warnings

The US Food and Drug Administration (FDA) already gathered stronger evidence to link nonsteroidal anti-inflammatory drugs (Nsaids) to heart failure.

FDA approves the use of Entresto

The U.S. Food and Drug Administration (FDA) already approved the use of the latest heart failure drug from Novartis. The drug, known as Entresto, was found to be potent in reducing death and hospitalizations related to cardiovascular diseases.

The Investigation into whether Johnson & Johnson Knew about their Harmful Uterine Device

Johnson & Johns is under investigation by the FBI for possible prior knowledge about dangers linked to one of their medical devices, the laparoscopic power morcellator, which is supposed to provide a minimally invasive alternative to hysterectomies and removal of fibroid tumors, but in reality, may have been spreading dangerous forms of cancers among its patients.

Pfizer Announces IBRANCE Clinical Trials Ended Early In Light of Promising News

In light of promising results conducted by an independent data monitoring committee, Pfizer’s newest treatment IBRANCE (Palbociclib) ended clinical trials early this week as phase 3 of the trials ended demonstrating improvement in progression-free survival in women who had undergone treatment for metastatic breast cancer.

FDA Issues Warning for the Quit-Smoking Drug Chantix

Chantix has helped many people quit smoking in the years since its release. However, on Monday the U.S. Food and Drug Administration issued a warning about the quit-smoking drug made by Pfizer Inc. According to the FDA, the drug has been associated with seizures and that some patients who drink while taking the drug may become aggressive or even black out.
1 2 3 4 5 6 7 8

Recommended Stories

Real Time Analytics